Escala Medical Ltd.

Truleaf Medical Ltd.

Truleaf Medicai Ltd.

Moran Sobol

Netanel Benichou

Benjamin Spenser

Shahar Harari

Edit Goldberg

Hagay Weisbrod

An apparatus for affixing a first tissue to a second tissue and methods of manufacturing and using the same. The apparatus comprises an elongated needle; a handle disposed at a proximal end of the elongated needle; a superelastic anchor disposed within the elongated needle, the anchor comprises: at least one normally-expanded elongated hook that is biased to a contracted state to fit within the elongated needle; a securing element; and an advancement mechanism triggerable by the handle and being configured to: eject the anchor out of a distal end of said elongated needle to allow the elongated hook to extend distally outward from the longitudinal axis of the elongated needle, into or beyond a tissue, and following the ejection of the anchor, eject the securing element from the apparatus to prevent movement of the anchor in at least one direction.

Anchor delivery system and method

Apparatus and methods are described for treating a subject with a diseased atrioventricular valve. A docking element is implanted within the subject's atrium such that no portion of the docking element extends through the subject's atrioventricular valve. The docking becomes anchored to tissue of the atrium at least partially via ingrowth of the tissue of the atrium. The docking element includes a ring, which is implanted at the annulus of the atrioventricular valve, and a frame having a height of at least 15 mm, which extends upwardly from the ring. A prosthetic atrioventricular valve apparatus is placed at least partially inside the docking element subsequent to the ingrowth of the tissue of the atrium having occurred, and becomes anchored to the docking element, at least partially by radially expanding against the ring. Other applications are also described.

Docking elements

Apparatus and methods are described for treating a subject with a diseased mitral valve. A docking element is implanted within the subject's left atrium such that no portion of the docking element extends through the subject's mitral valve. The docking element includes a ring having a smaller size than that of the subject's mitral annulus, and which configured to be implanted within 15 mm of the mitral annulus. A frame extends upwardly from the ring, a portion of the frame being configured to be disposed in a vicinity of the mitral annulus and to generate tissue ingrowth from the subject's atrial walls in the vicinity of the mitral annulus. A material disposed between the portion of the frame and the ring is configured to form a seal between atrial walls in the vicinity of the mitral annulus and the ring. Other applications are also described.

Apparatus and methods are described for treating a subject with a diseased mitral valve. A docking element () is implanted within the subject's left atrium such that no portion of the docking element extends through the subject's mitral valve. The docking becomes anchored to tissue of the left atrium at least partially via ingrowth of the tissue of the left atrium. The docking element () includes a ring (), which is implanted at the subject's mitral valve annulus, and a frame (), having a height of at least 15 mm, which extends upwardly from the ring. A prosthetic mitral valve apparatus () is placed at least partially inside the docking element subsequent to the ingrowth of the tissue of the left atrium having occurred, and becomes anchored to the docking element, at least partially by radially expanding against the ring. Other applications are also described.

Growing community of inventors

Haifa, Israel

Moran Sobol